Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

Data Compilation
#PharmaFlow

Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

Stock Recap
#PipelineProspector

Ciprofloxacin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 10 USDMF, 7 CEP/COS, 7 JDMF, 4 EU WC, 5 KDMF, 5 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

43 Drugs in Development

43 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

662 FDF Dossiers, 60 FDA Orange Book, 343 Europe, 3 Canada, 23 Australia, 88 South Africa, 145 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML), SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc, 5 SPI Pharma, 2 Seqens, 5 DKSH, 2 Jai Radhe Sales, 7 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 13 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 35 BASF, 1 BioSpectra, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 32 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 30 Roquette, 13 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 57 Coating Systems & Additives, 42 Direct Compression, 41 Disintegrants & Superdisintegrants, 34 Thickeners and Stabilizers, 34 Controlled & Modified Release, 32 Granulation, 31 Solubilizers, 26 Parenteral, 22 Lubricants & Glidants, 21 Topical, 20 Film Formers & Plasticizers, 19 Co-Processed Excipients, 17 Taste Masking, 11 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 7 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

DIGITAL CONTENT

8 DATA COMPILATION #PharmaFlow, 55 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 336 Finished Drug Prices, 2 Annual Reports

MARKET PLACE

69 APIs, 38 FDF Dossiers

PATENTS & EXCLUSIVITIES

9 US Patents, 8 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 10 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/10/2024	Neuland Laboratories	India	NEULAND LABORATORIES LTD	18465	CIPROFLOXACIN USP	2005-06-24	Active	II	Complete	2013-04-02	2013-09-27
28/10/2024	Bayer AG	Germany	BAYER AG	10353	CIPROFLOXACIN HYDRATED DRUG SUBSTANCE	1993-07-13	Active	II	N/A

Ciprofloxacin

Ciprofloxacin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers

10 USDMF

7 CEP/COS

7 JDMF

4 EU WC

5 KDMF

5 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

43 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

662 FDF Dossiers

60 FDA Orange Book

343 Europe

3 Canada

23 Australia

88 South Africa

145 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 200MG/100ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 400MG/200ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE, SUSPENSION;OTIC - 6% (60MG/ML)

SUSPENSION/DROPS;OTIC - 0.3%;0.1%

RELATED EXCIPIENT COMPANIES

2 Rochem International Inc

5 SPI Pharma

2 Seqens

5 DKSH

2 Jai Radhe Sales

7 Faran Shimi Pharmaceutical

10 Boai NKY Pharmaceuticals Ltd

13 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 ACG Worldwide

12 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

35 BASF

1 BioSpectra

1 Clariant

11 Corel Pharma Chem

6 DFE Pharma

2 Finar

14 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

32 Kerry

4 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

2 Nanjing Bold Chemical

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

9 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

30 Roquette

13 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

12 Sigachi Industries

3 The Dow Chemical Company

3 Ulanqab Kema New Material

1 Valens Pharmachem

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

INJECTABLE;INJECTION - 200MG/100ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 400MG/200ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons